Hynes, Sinéad M. http://orcid.org/0000-0002-3199-7355
Dwyer, Christopher P. http://orcid.org/0000-0001-5935-4338
Alvarez-Iglesias, Alberto http://orcid.org/0000-0001-5011-9008
Rogers, Fionnuala http://orcid.org/0000-0002-1001-7653
Joyce, Robert A. http://orcid.org/0000-0001-5572-0804
Oglesby, Megan H. http://orcid.org/0000-0001-8772-5546
Moses, Anusha http://orcid.org/0000-0002-0267-571X
Bane, Eimear http://orcid.org/0000-0002-5318-3352
Counihan, Timothy J. http://orcid.org/0000-0001-8305-0174
Charamba, Beatrice http://orcid.org/0000-0002-6579-2665
,
Funding for this research was provided by:
Health Research Board (DIFA-FA-2018-027)
Article History
Received: 23 March 2024
Accepted: 2 September 2024
First Online: 24 September 2024
Declarations
:
: Ethical approval was awarded by Galway University Hospitals on 13.08.2019, Ref: C.A 2231 and was conducted at the University of Galway. Ethical approval of trial amendments, in light of COVID-19 was awarded Galway University Hospitals on 09.04.2020. All research has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All participation was conducted based on informed consent.
: The authors declare that they have no conflict of or competing interests to report.
: University of Galway, University Rd., Galway, Ireland, H91 TK33, + 353 (0)91 524411.
: The protocol for this trial was published: Dwyer, C. P., Alvarez-Iglesias, A., Joyce, R., Counihan, T. J., Casey, D., & Hynes, S. M. (2020). Evaluating the feasibility and preliminary efficacy of a Cognitive Occupation-Based programme for people with Multiple Sclerosis (COB-MS): protocol for a feasibility cluster-randomised controlled trial. <i>Trials</i>, <i>21</i>(1), 1–12.] and the protocol was subsequently updated in light of COVID-19 [Dwyer, C.P., Alvarez-Iglesias, A., Joyce, R. et al. (2023). Evaluating the feasibility and preliminary efficacy of a Cognitive Occupation-Based programme for people with Multiple Sclerosis (COB-MS): an update to the protocol for a feasibility cluster-randomised controlled trial. Trials 24, 48. 10.1186/s13063-023–07080-y].